Clinical Trial Update: Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing radical concurrent chemoradiotherapy with cisplatin, 5-FU, and a PD-1 antibody for non-metastatic rectal squamous cell carcinoma; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Rectal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING